State funding supports domestic EDA growth in China, while Insilico Medicine seeks to build a yuan fund.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
State funding supports domestic EDA growth in China, while Insilico Medicine seeks to build a yuan fund.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insilico Medicine
American biotechnology company
Nothing else this week.
-
Mentor Graphics
company
Nothing else this week.